pacreatic cancer
Conditions
Interventions
Custody of 5FrENPD catheter
Sponsors
Hiroshima University Hospital Department of Gastroenterology and Metabolism
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The age of the time of the agreement merit is more than 20-year-old inpatient. (2) The patient pancreatic cancer is doubted as a result of the diagnostic imaging and who needs implementation of ERCP (3) The patient who can get consent by a document about participation of this research
Exclusion criteria
Exclusion criteria: (1) The patient who has that the acute stage of the acute pancreatitis. (2) Patient with the past of a big surgery-like operation in the liver,the gallbladder,and the pancreas (3) Patient with the past of a gastric resection. (4) The patient who can think unresectable pancreatic cancer in diagnostic imaging. (5) The patient who admits many viscous liquid in the pancreatic duct and suspects IPMN (Intraductal Papillary Mucinous Neoplasm) clinically. (6) The patient for whom it's difficult to receive informed consent (7) Patient with the past which manifested the allergic reaction by the medicine used in case of usual ERCP (pancreatic enzyme inhibitor/antibiotic/downer/antispastic/painkiller/contrast medium) and a polyurethane product. (8) Additionally the patient who judged that a study doctor in attendance was unsuitable for registration of this research(pregnant woman).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The accuracy of the pancreatic juice cytology using an ENPD catheter | — |
Countries
Japan
Contacts
Public ContactAkinori Shimizu
Hiroshima University Hospital Department of Gastroenterology and Metabolism
Outcome results
None listed